ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,124Medicare Part D Prescriptions Filled, Including Refills

Rank: 21 out of 96

$624K Total Retail Price of All Prescriptions

Rank: 23 out of 96

383 Patients Receiving at Least One Drug in Part D
97%Patients 65 Years and Older
30% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 383 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

4% of this provider’s 383 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

1% of this provider’s 9,900 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

33% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
SIMVASTATIN 500 467 1 1
LEVOTHYROXINE SODIUM 482 479 2 3
FUROSEMIDE 337 337 3 4
OMEPRAZOLE 320 295 4 5
DONEPEZIL HCL 280 280 5 8
AMLODIPINE BESYLATE 269 266 6 2
ZOLPIDEM TARTRATE 204 204 7 18
NAMENDA 201 201 8 11
MIRTAZAPINE 193 193 9 14
QUETIAPINE FUMARATE 187 187 10 32
SERTRALINE HCL 183 183 11 15
ESCITALOPRAM OXALATE 156 156 12 24
METOPROLOL TARTRATE 126 126 13 7
LISINOPRIL 123 120 14 10
LOSARTAN POTASSIUM 123 123 14 23
METOPROLOL SUCCINATE 118 117 16 9
POTASSIUM CHLORIDE 116 116 17 19
FAMOTIDINE 110 108 18 21
CITALOPRAM HBR 107 107 19 25
METFORMIN HCL 102 102 20 13
ATORVASTATIN CALCIUM 98 98 21 12
LACTULOSE 97 97 22 37
ADVAIR DISKUS 93 93 23 46
ATENOLOL 90 90 24 30
CLOPIDOGREL 88 88 25 27
TRAZODONE HCL 87 87 26 38
WARFARIN SODIUM 86 86 27 6
LEVOFLOXACIN 85 84 28 59
PLAVIX 85 85 28 42
CARBIDOPA-LEVODOPA 85 85 28 48
IPRATROPIUM BROMIDE 84 83 31 124
HUMALOG 84 84 31 120
FENTANYL 80 80 S2 33 50
PANTOPRAZOLE SODIUM 78 78 34 44
ALLOPURINOL 77 66 35 82
TAMSULOSIN HCL 74 74 36 29
DIVALPROEX SODIUM 74 74 36 41
TRAMADOL HCL 69 54 38 35
ACTONEL 67 67 39 232
SEROQUEL 67 67 39 106
LANTUS 65 65 41 68
HYDROCHLOROTHIAZIDE 64 64 42 16
PREDNISONE 60 60 43 58
GABAPENTIN 56 56 44 20
LEXAPRO 56 56 44 92
CARVEDILOL 55 55 46 22
SPIRONOLACTONE 55 55 46 70
DIGOXIN 54 54 48 34
NEXIUM 54 54 48 40
IPRATROPIUM-ALBUTEROL 54 54 48 57
ENALAPRIL MALEATE 53 53 51 28
EXELON 52 52 52 47
LEVETIRACETAM 51 51 53 61
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 4, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.